New diabetes clinical trial: Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
Published on: October 16, 2024 at 11:00PM Conditions : Relapsed Refractory Multiple Myeloma (RRMM) Interventions : Drug: Elranatamab; Drug: Mezigdomide; Drug: Dexamethasone Sponsors : YOUNGIL KOH Not yet recruiting https://ift.tt/3AtgSUj